The Federal Reserve raised interest rates for the first time in three years on Wednesday, and the Dow still managed to shed more than 600 points once Chair Kevin Warsh’s hawkish tone on inflation sank in. But scroll past the grim headline numbers and today’s list of top gaining stocks today reveals real pockets of strength: an optical components maker topped the entire S&P 500 on a wave of bullish analyst coverage, an aircraft leasing company announced a $500 million buyback, and a tiny biotech nearly doubled on a single licensing deal. Here are the 10 stocks that had the best day in the market today.
Wednesday’s Broader Market Context:
| Metric | Reading |
|---|---|
| Dow Jones Industrial Average | −631.21 pts (−1.21%) to 51,461.90 |
| S&P 500 | −0.45% to 7,551.81 |
| Nasdaq Composite | −0.01% to 25,978.42 (essentially flat) |
| Fed Decision | +25 bps hike to 3.75%–4.00% (first hike since 2023) |
| 10-Year Treasury Yield | Briefly topped 5%, highest since 2007 |
| Notable Sector Split | Optical networking and select semiconductor names bucked the broader downtrend |
Even as banks and truckers had one of their roughest sessions of the month, a handful of distinct, catalyst-driven stories delivered genuinely strong single-day gains.
1. Lumentum Holdings (LITE) | Up 6.4% to 9.4%
An Optical Laser Maker Tops the Entire S&P 500
Lumentum shares surged as much as 9.4%, leading the entire S&P 500, after Deutsche Bank initiated coverage with a Buy rating and a bullish $1,200 price target, calling the company’s III-V laser technology “critical” and non-substitutable across future optical networking architectures.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Approx. Price | $895.20–$908.23 |
| Day’s Move | +6.4% to +9.4% (varied by intraday measurement) |
| 52-Week High | $1,085.68 |
| Average Analyst Price Target | ~$1,142.92–$1,148 |
| Deutsche Bank New Target | $1,200 (new Buy initiation) |
| Evercore ISI New Target | $1,100 (new Outperform initiation) |
Why It Gained:
Lumentum’s high-profile presence at ECOC 2026, the European Conference on Optical Communications, coincided with the CEO raising long-term guidance and targeting roughly $40 in earnings power by fiscal 2028, driven by a surge in orders for higher-margin optics tied to AI accelerator connectivity. Rothschild & Co Redburn separately lifted its target to $1,294.85.
Bull Case: Two major new analyst initiations landing the same week, combined with a raised long-term earnings outlook and genuine order momentum in AI-driven optical networking, suggest Lumentum’s re-rating is backed by fundamentals rather than pure sentiment.
Bear Case: Multiple Lumentum insiders filed Form 4 and Form 144 stock sales in August, and the stock remains a high-beta AI infrastructure proxy that has been hit hard earlier in the week alongside broader chip-sector weakness tied to AI-slowdown fears.
Technicals: Today’s rally recovers meaningful ground from earlier-week weakness, though shares remain roughly 16% below their 52-week high of $1,085.68.
Forecast: With Street price targets now clustered well above $1,100, continued strength likely depends on Lumentum converting its stated order surge into confirmed revenue in upcoming quarters.
Why This Matters: Lumentum topping the entire S&P 500 on a day when the broader market fell shows how selectively investors are still willing to reward specific AI-infrastructure sub-sectors even amid broader macro anxiety.
2. FTAI Aviation (FTAI) | Up 7.59% to $189.83
A $500 Million Buyback Signals Confidence From the Board
FTAI Aviation shares jumped as much as 7.59% to $189.83 after the aircraft leasing and MRO company’s board authorized a new $500 million share repurchase program that can run through September 2029.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Closing Price | $189.83 (from $176.44 prior close) |
| Day’s Move | +7.59% |
| Market Cap | ~$18.13B |
| P/E Ratio | ~38.34x |
| Morgan Stanley Price Target | $360 (raised) |
| Recent EBITDA | $996M trailing twelve months (tracking toward $1B target) |
Why It Gained:
Management appeared at Morgan Stanley’s 14th Annual Laguna Conference the same day, outlining a broadening growth plan including a new $2.0 billion warehouse facility (expandable to $3.0 billion) for its FTAI Strategic Capital business, pushing total warehouse funding to $5.5 billion in under two years — with the buyback serving as a direct signal that management believes the stock doesn’t fully reflect the underlying business outlook.
Bull Case: A cash-funded $500 million buyback, a raised Morgan Stanley price target to $360, and continued growth in the high-margin aerospace products segment all support the case that today’s move reflects genuine business momentum, not just capital-return optics.
Bear Case: Barclays trimmed its own price target to $310 the same day, and current EBITDA margins of 28-30% are down from roughly 40% earlier in the business cycle — a deliberate trade-off management has made to expand market share, but one that leaves near-term profitability lower than historical norms.
Technicals: FTAI has had 49 moves greater than 5% over the past year, reflecting a genuinely high-volatility stock where today’s reaction — while significant — sits within its normal trading behavior.
Forecast: With Morgan Stanley’s $360 target implying substantial upside from current levels, continued execution on the $450 million 2027 adjusted EBITDA goal will be the key confirming data point for whether today’s optimism is warranted.
Why This Matters: FTAI’s buyback and expanding capital-markets infrastructure show a company deliberately building financial flexibility during a period when broader market volatility has made external capital more expensive to raise.
3. GE Vernova (GEV) | Up 4.7% to 5.42%
A Conference Appearance Reignites the Power-Demand Story
GE Vernova shares rose as much as 5.42% to $930.65 after CEO Scott Strazik outlined a rising backlog, higher pricing, and plans to expand gas-turbine output without building new plants at Morgan Stanley’s Laguna Conference.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Closing Price | $930.65 |
| Day’s Move | +4.7% to +5.42% |
| 52-Week Range | $530.16 – $1,195.94 |
| Market Cap | ~$248B |
| P/E Ratio | ~26.45x |
| Total Deployed in Buybacks (through Q2 2026) | ~$6.944B |
Why It Gained: Strazik confirmed strong electrification and clean-energy spending remains intact even as onshore wind stays soft, and management’s confidence in expanding gas-turbine capacity without new plant construction gave investors a fresh data point on operational leverage — a welcome signal after the stock had given back gains from a sharp selloff earlier in the week following a bearish analyst initiation.
Bull Case: A backlog exceeding $200 billion, doubled free cash flow guidance of $11.5–$12.5 billion, and a return on assets of 14.22% all suggest the earlier-week selloff was, as one analyst put it, “technical rather than fundamental.”
Bear Case: InvestingPro analysis places GE Vernova above its estimated fair value, among the more overvalued names in the market, and the stock’s wide 52-week range ($530–$1,196) reflects genuine ongoing disagreement about how to value its long-cycle power business.
Technicals: Today’s bounce recovers a portion of a 17% drop earlier in the week, though shares remain meaningfully below their 52-week high.
Forecast: With one Wall Street analyst arguing 65% upside could materialize as the $176 billion backlog converts to revenue, GE Vernova’s trajectory likely hinges on confirming that this week’s volatility was sentiment-driven rather than a genuine reassessment of demand.
Why This Matters: GE Vernova’s rebound shows how quickly sentiment can swing in the AI-power-demand trade — the same order book that drove a sharp selloff days earlier is now being cited as the reason for today’s recovery.
4. Tempest Therapeutics (TPST) | Up 39.07%
A Micro-Cap Biotech Nearly Doubles on a Single Licensing Deal
Tempest Therapeutics shares surged 39.07% to $1.05 after the company secured an exclusive option to license Hebei Senlang’s CD7-targeted lentiviral in vivo CAR-T platform, led by a Phase 1 BCMA/GPRC5D dual-targeting candidate.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $1.05 |
| Day’s Move | +39.07% |
| Deal Structure | Exclusive licensing option |
| Licensed Asset | CD7-targeted in vivo CAR-T platform |
| Lead Candidate | Phase 1 BCMA/GPRC5D dual-targeting CAR-T |
| Sector | Clinical-stage oncology biotech |
Why It Gained: In vivo CAR-T technology — which aims to reprogram immune cells directly inside the body rather than through the complex, expensive ex vivo manufacturing process used by approved CAR-T therapies — represents one of oncology’s most closely watched next-generation approaches, and today’s licensing option gives Tempest a foothold in that space at a fraction of what a full acquisition would cost.
Bull Case: In vivo CAR-T platforms could dramatically reduce the manufacturing complexity and cost that has limited current cell-therapy accessibility, and securing an option (rather than committing to a full license immediately) gives Tempest flexibility to evaluate the platform’s data before deeper investment.
Bear Case: As a sub-$2 stock, Tempest remains an extremely early-stage, high-risk biotech name, and an “exclusive option to license” is a preliminary step — not a finalized deal — meaning today’s enthusiasm could prove premature if Tempest ultimately doesn’t exercise the option.
Technicals: A 39% single-day move on a microcap biotech reflects classic binary-catalyst trading behavior, with volume likely far exceeding typical levels for a stock of this size.
Forecast: Watch for Tempest’s decision on whether to formally exercise its licensing option, along with any early data disclosures from Hebei Senlang’s Phase 1 program, as the next confirming or disconfirming catalysts.
Why This Matters: Tempest’s move is a reminder that even preliminary licensing agreements in cutting-edge therapeutic areas like in vivo CAR-T can move a microcap stock dramatically — a pattern worth watching as more biotechs chase next-generation cell therapy technology.
5. Intel Corporation (INTC) | Up 4% to 7.2%
A Potential Deal With SK Hynix Reignites the Turnaround Story
Intel shares jumped as much as 7.2% to $104.13 after Reuters reported that South Korean chipmaker SK Hynix is in exploratory talks with Intel to manufacture memory chips in the U.S., potentially using Intel’s long-delayed Ohio manufacturing campus.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $102.14–$104.13 |
| Day’s Move | +4% to +7.2% |
| YTD Performance | +171% to +174% |
| Distance From 52-Week High | ~30% below June 30 all-time high of $142.35 |
| Analyst Ratings | 34 of 46 covering brokerages at Hold or worse |
| Options Activity | 278,000+ calls traded in first trading hour, double the average |
Why It Gained: The discussions reportedly involve at least two potential structures — SK Hynix leasing part of Intel’s roughly 1,000-acre Ohio campus, or a joint venture with major cloud companies to secure a more stable memory chip supply — either of which would give Intel a much-needed anchor tenant for a manufacturing site that originally required an estimated $100 billion to fully develop.
Bull Case: Any deal that fills Intel’s underutilized Ohio manufacturing footprint would represent a major validation of Intel’s foundry strategy, and heavy options call-buying activity suggests traders see meaningful further upside if talks advance.
Bear Case: SK Hynix explicitly stated “no matters have been determined at this stage,” and any advanced memory technology transfer could face South Korean regulatory scrutiny under the Industrial Technology Protection Act — meaning today’s rally is built entirely on speculation about a deal that may never materialize.
Technicals: Despite today’s pop, the majority of covering analysts (34 of 46) remain at Hold or worse, reflecting persistent skepticism about Intel’s turnaround even after a 171%+ year-to-date rally.
Forecast: Any formal statement from either company confirming deal structure, scope, or timing would be the clearest next catalyst — until then, expect continued speculative volatility tied to headline reports.
Why This Matters: Intel’s reaction shows how much investor appetite remains for any sign that its costly domestic manufacturing bet is finally attracting outside tenants, even on unconfirmed, exploratory reports.
6. SK Hynix (SKHY) | Up 2.2% to 3.3%
The Other Side of the Potential Chip Manufacturing Deal
SK Hynix’s U.S.-listed shares climbed alongside Intel, rising as much as 3.3% to $180.52, as the same reported exploratory talks about U.S. memory chip production lifted both companies simultaneously.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $178.63–$180.52 |
| Day’s Move | +2.2% to +3.3% |
| Business | High-bandwidth memory (HBM) and DRAM/NAND flash |
| Existing U.S. Investment | $4B HBM production base groundbreaking in Indiana (last month) |
| Read-Through Peer | Micron Technology (MU), barely moved (+0.9%) |
Why It Gained: As one of the world’s leading suppliers of high-bandwidth memory used in AI processors, SK Hynix’s participation in potential U.S. memory manufacturing talks builds on its existing American investment strategy, with the company’s own spokesperson confirming it is “reviewing various measures, including establishing additional production bases” without committing to specifics.
Bull Case: SK Hynix already has a track record of following through on U.S. investment commitments, evidenced by its Indiana HBM facility groundbreaking last month, lending credibility to today’s speculative talks.
Bear Case: Any advanced memory technology transfer to the U.S. could face South Korean government scrutiny given the strategic sensitivity of HBM and DRAM technology, and the muted reaction from Micron suggests the market isn’t yet pricing this as a major competitive threat or opportunity for the broader memory sector.
Technicals: SK Hynix’s more modest gain relative to Intel’s reflects the market’s assessment that Intel has more to gain from securing an anchor tenant than SK Hynix has to gain from a new manufacturing location.
Forecast: As with Intel, any formal confirmation of deal terms would be the next major catalyst — until then, expect the stock to trade in tandem with Intel on any fresh reporting.
Why This Matters: SK Hynix’s participation in today’s rally underscores how central Korean memory manufacturers have become to the broader U.S. AI supply chain narrative, with domestic manufacturing partnerships increasingly seen as strategically valuable regardless of near-term financial impact.
7. Coherent Corp (COHR) | Up 5.6%
Optical Networking’s Broader Rebound Lifts a Second Name
Coherent shares climbed 5.6% to $286.42, rebounding alongside Lumentum as optical networking names recovered from a rough start to the week tied to broader AI-sentiment weakness.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $286.42 |
| Day’s Move | +5.6% |
| Sector | AI photonics / optical networking |
| Sector Peer | Lumentum (+6.4% to +9.4% same session) |
| Recent Context | Both stocks were hit hard earlier in the week on AI-slowdown fears |
Why It Gained: Coherent’s rally tracked Lumentum’s move nearly in lockstep, reflecting a broader sector-wide recovery in AI-linked optical components names as investors reassessed earlier-week selling that had been driven by AI industry leaders’ public comments about safety and pacing concerns, rather than any change in underlying demand for optical networking hardware.
Bull Case: As one of the two clearest pure-play beneficiaries of AI data-center optical connectivity demand, Coherent’s rebound alongside Lumentum suggests the market is treating this week’s earlier AI-sentiment selloff as an overreaction rather than a fundamental repricing.
Bear Case: Coherent and Lumentum’s near-identical percentage moves suggest today’s rally is a broad sector reversal rather than a company-specific catalyst, meaning Coherent could give back gains just as quickly if AI-sentiment concerns resurface.
Technicals: Today’s bounce recovers meaningful ground within a stock that has shown significant volatility tied to broader AI-infrastructure sentiment swings throughout 2026.
Forecast: Coherent’s trajectory will likely continue tracking Lumentum and the broader AI-photonics complex until a distinct, company-specific catalyst (such as an earnings report or major contract announcement) provides independent direction.
Why This Matters: Coherent’s paired rally with Lumentum illustrates how tightly correlated the handful of pure-play AI optical component makers have become, with sentiment swings in one typically transmitting almost immediately to the other.
8. Dell Technologies (DELL) | Up 5%
Pricing Power Commentary and a $5 Billion Debt Raise
Dell Technologies shares rose 5% after CEO Michael Dell told investors that structural chip shortages are likely to intensify in 2027 relative to 2026, and that the company intends to pass rising hardware costs through to customers — a signal of durable pricing power that reassured investors.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $570.00 (intraday high $576.75) |
| Day’s Move | +5% |
| 52-Week Range | $110.22 – $576.75 (new all-time high set this week) |
| Average Analyst Price Target | $570.48 |
| Analyst Consensus | Buy (29 analysts) |
| Recent Capital Raise | $5B senior unsecured notes (completed Sept. 15, four tranches) |
Why It Gained: Dell’s subsidiaries completed a $5 billion senior unsecured notes offering the day before, providing substantial capital to fund its AI infrastructure buildout, while Silver Lake’s continued, well-telegraphed pattern of gradually reducing its equity stake was absorbed by the market without disruption.
Bull Case: A CEO explicitly signaling the ability to pass rising component costs through to customers — rather than absorbing them — indicates genuine pricing power in a tight AI-server hardware market, and the fresh $5 billion in capital supports continued infrastructure investment.
Bear Case: Dell trades near the top of its 52-week range after a 350%+ rally, leaving limited room for error, and continued Silver Lake insider selling — even if well-telegraphed — represents a persistent source of share supply that could cap further upside.
Technicals: Today’s move pushed shares to a fresh all-time high, extending an already powerful multi-month uptrend built on AI server demand.
Forecast: With chip shortages expected to intensify into 2027 per management’s own commentary, Dell’s ability to maintain margins through pricing actions will be the key data point to track in upcoming quarters.
Why This Matters: Dell’s rally on pricing-power commentary, rather than a formal earnings beat, shows how closely the market is now parsing every management comment for signs of how AI-hardware demand and cost inflation will interact going forward.
9. Axon Enterprise (AXON) | Up 4.08%
A Bounce-Back From Yesterday’s Convertible Note Selloff
Axon Enterprise shares rose 4.08% today, recovering a portion of yesterday’s decline that followed the public safety technology company’s disclosure of a $1.0 billion convertible senior notes offering.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Price | $460.11 |
| Day’s Move | +4.08% |
| Prior Day’s Move | Declined on $1B convertible note offering announcement |
| Business | Public safety technology (body cameras, TASER devices, cloud software) |
| Sector | Government and public safety technology |
Why It Gained: With the initial headline risk of yesterday’s $1 billion convertible note offering now digested by the market, investors appeared to refocus on the underlying capital structure benefits of the raise — including the capped call transactions specifically designed to limit shareholder dilution — producing a technical bounce back toward pre-announcement levels.
Bull Case: Today’s recovery suggests yesterday’s selloff may have been an overreaction to headline risk rather than a genuine repricing of Axon’s underlying business fundamentals, which remain intact regardless of the financing structure.
Bear Case: A single day’s bounce doesn’t fully offset yesterday’s decline, and the approximately 7.74 million in potential dilutive shares tied to the convertible notes remains a real overhang on the stock’s longer-term share count.
Technicals: Today’s gain retraces a meaningful portion of yesterday’s decline, though shares remain below levels seen before the convertible note announcement.
Forecast: Axon’s stock will likely stabilize once the convertible notes are fully priced and the capped call structure’s specific terms are disclosed, removing the remaining uncertainty around dilution.
Why This Matters: Axon’s rebound demonstrates how quickly markets can reprice capital-structure headline risk once the initial shock fades and investors have time to evaluate the actual mechanics of a financing deal.
10. AXT Inc (AXTI) | Up in Broader Semiconductor Recovery
A Substrate Maker Rides the AI Chip Rebound
AXT Inc, a maker of indium phosphide and gallium arsenide semiconductor substrates, moved higher today as part of a broader recovery in AI-related semiconductor stocks ahead of the Federal Reserve’s rate decision.
Full Data Snapshot:
| Metric | Value |
|---|---|
| Sector | Semiconductor substrate materials |
| Key Products | Indium phosphide and gallium arsenide substrates |
| Recent Context | Technical rebound from a sharp monthly decline |
| Prior Overhang | Chinese export permit delays for indium phosphide substrates |
Why It Gained: AXT’s gains reflected a technical rebound as investors reassessed the stock as potentially undervalued following recent concerns over Chinese export permit delays, with the broader semiconductor sector’s recovery providing a supportive backdrop for smaller substrate suppliers that feed into the AI chip manufacturing supply chain.
Bull Case: As a specialized substrate supplier to the broader compound semiconductor industry, AXT benefits directly from any recovery in AI chip manufacturing sentiment, and today’s rebound suggests the market may have overreacted to the export-permit-delay concerns.
Bear Case: Chinese export permit delays for indium phosphide substrates represent a genuine, unresolved supply chain risk that could resurface and pressure the stock again if the underlying regulatory issue isn’t fully resolved.
Technicals: Today’s bounce is characterized as a technical rebound from oversold levels rather than a fundamentals-driven re-rating, suggesting the move could prove more fragile than gains built on genuine new catalysts.
Forecast: Resolution of the Chinese export permit situation will be the key variable determining whether today’s rebound has staying power or represents only a temporary technical bounce.
Why This Matters: AXT’s participation in today’s broader semiconductor rally shows how even niche materials suppliers several steps removed from headline chip names can catch a bid when overall sector sentiment improves.
Sector Sentiment Snapshot & Forecast
Today’s gainers cluster around a clear theme: AI-adjacent optical and semiconductor names staged a notable recovery (Lumentum, Coherent, Intel, SK Hynix, AXT) after a rough start to the week driven by AI-industry-leader commentary about safety and development pacing — evidence that this week’s selloff may have been more sentiment-driven than fundamental. Capital-allocation announcements (FTAI Aviation’s buyback, GE Vernova’s conference commentary, Dell’s pricing-power signal) all drove genuine, catalyst-specific gains independent of the broader macro picture. And binary biotech catalysts (Tempest Therapeutics) reminded investors that micro-cap clinical-stage names can still deliver dramatic single-day moves regardless of what the Fed does with interest rates.
With the Fed’s hawkish dot plot suggesting at least one more 2026 hike, expect continued volatility across rate-sensitive sectors — but today’s action shows that company-specific catalysts, from buybacks to conference commentary to licensing deals, can still produce standout gains even on a broadly negative macro day.
At a Glance: Today’s Top 10 Gaining Stocks
| Ticker | Price | Day’s Move | Key Catalyst |
|---|---|---|---|
| LITE | ~$895–$908 | +6.4% to +9.4% | Deutsche Bank/Evercore new coverage, ECOC 2026 |
| FTAI | $189.83 | +7.59% | $500M share buyback authorization |
| GEV | $930.65 | +4.7% to +5.42% | Morgan Stanley conference, backlog commentary |
| TPST | $1.05 | +39.07% | CD7-targeted CAR-T licensing option |
| INTC | $102.14–$104.13 | +4% to +7.2% | SK Hynix U.S. memory chip talks |
| SKHY | $178.63–$180.52 | +2.2% to +3.3% | Intel manufacturing talks |
| COHR | $286.42 | +5.6% | Optical networking sector rebound |
| DELL | $570.00 | +5% | Pricing power commentary, $5B notes offering |
| AXON | $460.11 | +4.08% | Bounce-back from prior day’s selloff |
| AXTI | N/A | Sector rebound | AI semiconductor recovery |
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and micro-cap biotech and high-beta technology stocks carry elevated risk. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change. Some prices in this article are approximate, and reported percentage moves varied across sources depending on the time of measurement during the trading session. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.
About The Author
